Hospitals are adopting AI — with ~31.5 % early adopters — to enhance patient communication, optimize operations, and support proactive care.

Persistent staffing shortages are forcing providers to rethink care models, roles, and workflows to maintain capacity and close widening gaps.

An aging population is simultaneously straining hospitals, post-acute care, and the healthcare workforce.

Cyber threats are no longer just IT risks—they now directly disrupt patient care and clinical operations.

Employers are redesigning the benefits playbook to better align health benefits with workforce needs and talent strategy.

Consumers are shopping for healthcare with higher expectations and more data than ever before.

Employers are increasingly purchasing care directly to improve access, transparency, and cost control.

Rising drug costs are forcing tougher pharmacy management and contracting decisions.

OBBBA’s changes to ACA subsidies and premium tax credits are reshaping individual market rules and prompting renewed debate over how to maintain affordability and stability.

Regulators are stepping up efforts to strengthen compliance with healthcare price transparency requirements and make cost data more accessible and actionable for consumers.

Lawmakers and regulators are defining new permanent rules for telehealth coverage, reimbursement, and scope.

Reform in 2026 spans Medicare’s new drug‑price negotiation and Part D out‑of‑pocket caps, CMMI’s GLOBE and GUARD rebate models tied to international benchmarks, and heightened scrutiny of 340B and rebate practices - all reshaping the future of drug pricing.

Startups that fail to prove ROI face funding pressure, longer sales cycles, and consolidation, while companies showing real impact gain the advantage.

Startups are using AI, digital therapeutics, and virtual care to improve outcomes and reduce costs for chronic conditions.

Direct-to-consumer diagnostic platforms and retail health optimization products are expanding rapidly as patients increasingly bypass traditional medical gatekeepers to self-manage their health data, wellness strategies, and preventive care outside clinical settings.

Generative AI is speeding drug discovery and clinical trial design, helping startups bring therapies to market faster and more efficiently.